One year on: an update on IMID management during the pandemic

This webinar is the fourth in a series (the first in 2021) that will address issues that healthcare providers may face when they treat patients with immune-mediated inflammatory diseases (IMIDs) during the COVID-19 pandemic. This 1-hour session will start off with the faculty presenting a brief overview of the impact that COVID-19 has had on their fields of expertise over the past year. This will be followed by a discussion on how patient treatment approaches and clinical practice have changed due to the pandemic and what the biggest challenges, including vaccination, are from both clinical and societal perspectives. A panel discussion and interactive Q&A session addressing questions from the audience will round off the webinar. At this time, viewers worldwide will have the opportunity to engage with the faculty.

Learning objectives

After this webinar, participants should be able to:

• Evaluate best practices in managing patients with immune-mediated inflammatory diseases during the current COVID-19 pandemic
• Understand the latest data on COVID-19 and apply the knowledge gained during the evolving pandemic to their own practice

Faculty

• Silvio Danese (Italy)
• Georg Schett (Germany)
• Diamant Thaçi (Germany)